Last reviewed · How we verify
L608 Inhalation Solution
At a glance
| Generic name | L608 Inhalation Solution |
|---|---|
| Sponsor | Pharmosa Biopharm Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults (PHASE1)
- Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- L608 Inhalation Solution CI brief — competitive landscape report
- L608 Inhalation Solution updates RSS · CI watch RSS
- Pharmosa Biopharm Inc. portfolio CI